Search Posts

Novartis CEO – Vas Narasimhan (Age – 47)

Harvard-trained physician Vasant (Vas) Narasimhan took control of Europe’s leading drug-making company Novartis AG from its eight-year-old chief Joseph Jimenez in 2018. Novartis CEO Vas Narasimhan is responsible for the company’s strategic decisions and cultural revamp. He is on a mission to turn Novartis into a dedicated medicines company to provide treatments for diseases through technologically-driven research & development work and unique approaches. Under him, the pharma company has improved its performance, revenue, and shareholder returns. Vas is focused on critical areas like radioligand, siRNA, and medicines for cancer, cardiovascular disorders, genetic disorders, etc. He tremendously supports the use of technology and data science to revolutionize treatment. For more inputs like Novartis CEO email address, Vas Narasimhan net worth, wife & Family, and Novartis CEO salary, immerse yourself in this wiki.

(Suggested: Eli Lilly CEO Email & Net Worth – David Ricks)

Novartis Competitors

Other notable drugmakers are:

  • Sanofi
  • Pfizer
  • AstraZeneca
  • Merck
  • Eli Lilly

Vas Narasimhan Net Worth – Novartis CEO Salary

As of 2023, Vasant “Vas” Narasimhan’s net worth can be estimated to be around 45-55 million USD. He reportedly makes 9-19 million USD yearly.

Novartis CEO Email Address | Vas Narasimhan Contact

You can send an email to [email protected] to connect with the pharma company’s top boss. He is also available on LinkedIn at https://www.linkedin.com/in/vasnarasimhan, Twitter @VasNarasimhan, and Instagram vasnarasimhan.

(Related: Pfizer CEO Email & Net Worth – Albert Bourla)

Novartis Net Worth – Is Novartis Profitable?

As of 2023, Novartis’s net worth can be between 215-225 billion USD. Yes, the Swiss multinational medicines company Novartis is profitable.

Career & Education – Company, University, & College

Vasant went to University of Chicago for a degree in biological sciences, Harvard Medical School for M.D., and the John F. Kennedy School of Government for masters in public policy. He first joined McKinsey & Co before getting absorbed by the drug manufacturing giant Novartis in 2005. In 2007, he headed the Meningitis franchise globally. Vas became US Marketing – VP in 2008. In 2012, he was Development – Global Head. For five months, he managed subsidiary Sandoz’s biopharmaceuticals and oncology injection division as business unit head at the global level. From 2014-2016, Narasimhan was Novartis’s Development division’s global head. In 2016, he became chief medical officer and drug development department’s global head. Finally, Vas was made CEO in 2018.

Vas Narasimhan Wiki – Age, Wife, Family, & More

Vas Narasimhan, age 47, married his wife Srishti Gupta in 2003. The couple with their two sons lives in Basel, Switzerland. He met his wife at Harvard. The 1976 born is a vegetarian, hailing from a Hindu Tamilian family. His birthplace is Pittsburgh. His mother worked at Public Service Electric and Gas Company as a nuclear engineer and father held an executive position at Hoeganaes Corporation. Fortune recognized him under the prestigious ‘40 under 40’ list in 2015. During his studies, he has been associated with public health initiatives, such as India’s child poverty, Botswana’s HIV treatment, etc. Vasant reads topics on philosophy, leadership, and history. He takes deep interest in conserving wildlife and the environment.

(Suggested: AstraZeneca CEO Email & Net Worth – Pascal Soriot)

About Novartis

The Swiss pharmaceutical company Novartis AG has its headquarters in Basel, Switzerland. It is one of the top five globally recognized drugmakers. Formed in 1996, the publicly listed multinational corporation offers medicines for a wide range of diseases, including Osteoporosis, Hypertension, Cancer, Obsessive-compulsive disorder, Schizophrenia, Malaria, Psoriasis, Heart failure, Diabetes Type 2, Alzheimer’s, ADHD, Asthma, COPD, Multiple sclerosis, Chronic iron overload, Fever, Epilepsy, etc.

Leave a Reply

Your email address will not be published. Required fields are marked *

Share via
Copy link